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In order to establish firm evidence for the health effects of dietary polyphenol consumption, it is essential to have quantitative information regard-
ing their dietary intake. The usefulness of the current methods, which rely mainly on the assessment of polyphenol intake using food records and
food composition tables, is limited as they fail to assess total intake accurately. This review highlights the problems associated with such methods
with regard to polyphenol-intake predictions. We suggest that the development of biological biomarkers, measured in both blood and urine, are
essential for making accurate estimates of polyphenol intake. However, the relationship between dietary intakes and nutritional biomarkers are
often highly complex. This review identifies the criteria that must be considered in the development of such biomarkers. In addition, we provide
an assessment of the limited number of potential biomarkers of polyphenol intake currently available.
Polyphenol: Flavonoid: Phenolic acid: Biomarker: Human subjects: Metabolism
In the last decade, there has been intense interest in the potential
health benefits of dietary-derived plant polyphenols. An ever-
increasing number of studies have described their antioxidant
properties and linked this to their proposed role in the preven-
tion of human disease. Plant polyphenols are abundant in the
human diet, particularly in fruit, vegetables and pulses which
have been consistently associated with a decreased risk of
cancer1–3, CVD4–6 and a range of other chronic disorders.
The likely active components of fruits, vegetables and pulses
are a group of phytochemicals, known as polyphenols. How-
ever, it has proved extremely difficult to quantitatively establish
the benefit afforded by polyphenols for a number of reasons: (1)
there is a great diversity of polyphenol content between foods;
(2) there is limited data regarding the polyphenol content of
specific foods within the commonly-used food composition
databases; (3) there are challenges in characterising and quan-
tifying habitual food intake; and (4) there is a limited under-
standing regarding the extent of absorption and metabolic fate
of individual polyphenols from particular foods.
Biological markers of nutrient exposure, as an alternative to
the more traditional dietary assessment tools, have been used
for many years. In this approach one or more biochemical moi-
eties are measured in an accessible fluid or tissue to provide a
semi-quantitative index of the exposure to individual food con-
stituents. For polyphenols, this may appear to be an attractive
approach. However, the relationship between dietary intake
and resulting concentrations of biomarkers in body fluids is
highly complex. Before a particular dietary component, or its
metabolite, can be used as a sensitive and accurate biomarker
of exposure to a specific polyphenol, a number of factors must
be realised. Firstly, a full understanding of the metabolism
of polyphenols in human subjects is required in order to select
credible biomarkers. Secondly, it is important to understand
the time–response relationship between polyphenol intake
and the appearance of the biomarker in biological fluids. Thirdly,
the precise dose–response relationship between the intake of a
specific polyphenol and the appearance of its biomarker is
essential. Finally, one must also have an understanding of the
extent to which certain physiological and environmental factors
affect the rate of polyphenol metabolism in human subjects. The
current review will highlight the criteria that should be given
consideration during the process of developing such biomarkers,
and summarises the strengths and limitations of a number of
potential biomarkers of polyphenol intake currently available.
Classification and structure of major dietary polyphenols
Polyphenols are naturally occurring non-nutritive plant com-
pounds, which can be classified into several groups based on
their structures. The main classes include flavonoids, phenolic
*Corresponding author: Dr Jeremy Spencer, fax: þ44 (0) 118 931 0080, email j.p.e.spencer@reading.ac.uk
Abbreviation: Tmax, time to maximum concentration.
British Journal of Nutrition (2008), 99, 12–22 doi: 10.1017/S0007114507798938
q The Authors 2008
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
acids, stilbenes and lignans. Fig. 1 illustrates the different
groups of polyphenols with a representative compound from
each group showing the characteristic chemical structure.
One of the major classes of polyphenols is flavonoids which
are identified by having a common structure consisting of two
aromatic rings, which are bound together by three carbon
atoms that form an oxygenated heterocycle (Fig. 1). Based
on the variation in the type of heterocycle involved, flavonoids
may be divided into six subclasses: flavonols, flavones, flava-
nones, flavanols, anthocyanins, and isoflavones. Individual
differences within each group arise from the variation in
number and arrangement of the hydroxyl groups and their
extent of alkylation and/or glycosylation. Phenolic acids are
abundant in food and can be classified into derivatives of ben-
zoic acid and derivatives of cinnamic acid. Polyphenolic com-
pounds also include stilbenes, which are compounds that
possess 1,2-diarylethene structures and lignans characterised
by a 1,4-diarylbutane structure.
Limitations in current methods used for estimation of
dietary intake: need for biomarkers
In nutrition studies, the intake of nutrients and non-nutrient diet-
ary components are usually determined using dietary assess-
ment methods such as diet histories, FFQ or diet diaries. This
food intake data is then translated into quantitative information
regarding the specific food components of interest using food
composition databases. Such methods rely on self-reporting of
dietary patterns by the study participants, and consequently
their accuracy is often uncertain. In particular, foods perceived
as being unhealthy such as high-fat and -sugar products or pro-
cessed foods are typically under-reported, with fruit and veg-
etable intakes, which represent the main dietary sources of
polyphenols, often being over-reported.
Dietary assessment methods
The translation of food composition into intakes of specific
dietary nutrients or non-nutrients is usually achieved using
food composition databases. For polyphenols this approach
is problematic, as currently available databases have only lim-
ited information on the diversity and concentration of poly-
phenols present in plant foods. These limitations arise
because, unlike most nutrients, there has been only a limited
systematic approach to comprehensively characterise and
quantify polyphenols in plant foods using standardised analyti-
cal methods. In addition, much of the available information
has been assembled from heterogeneous sources, in which
the original food sampling and description is uncertain.
Fig. 1. Classification and chemical structure of major classes of dietary polyphenols.
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For example, plant variety is a major determinant of the
polyphenol composition, with up to a 4-fold variation in flavo-
noid and phenolic acid content being reported in apples7 and
in yellow and red onions8.
Many other factors are also important. These include the
ripeness of the plant food at time of harvest, environmental
factors, such as UV exposure, and conditions of storage and
processing. Studies investigating the effect of ripeness on the
concentration of polyphenols in plants have shown that, in
general, phenolic acid concentrations decrease during ripening,
whereas the levels of anthocyanins increase9. In addition, as
many polyphenolic compounds possess anti-microbial activity
in plants, their concentration in plant foods would be expected
to be higher if plants had experienced bacterial or viral infec-
tion during growth10,11. This is observed in plants grown under
organic conditions, where the polyphenol content has been
reported to be higher than in non-organically grown varieties12.
This is presumably due to the fact that organic crops are grown
in the absence of exogenous herbicides and pesticides which
encourages the synthesis of endogenous polyphenols in
response to plant stress. Storage of plant-derived materials
has also been shown to affect polyphenols content as many
are easily oxidised. For example, storage of apple juice at
room temperature results in a 60% loss of quercetin and
total loss of procyanidins13,14 whereas cold storage results in
much smaller decreases in polyphenol content15.
Further complexity arises due to the uneven distribution of
polyphenols in plant tissues and/or the loss or enrichment of
specific polyphenols during food processing. For example, in
apple, quercetin is found in the peel (1mg/g fresh weight)
with peeled fruit containing no flavonols16. Similarly, poly-
phenols in wheat grain are located predominantly in outer
layers and are usually lost during refining of the flour17. In
contrast, the processing of fruits into juices often results in
the solubilisation or extraction of phenolic compounds from
the skin, resulting in higher than expected concentrations in
the juice. This is illustrated by the presence of significant
levels of phloridzin in apple juice even though it is primarily
confined to the pips of apples18. Cooking may also have a
major effect with both onions and tomatoes losing between
75% and 80% of their initial quercetin content following boil-
ing, 65% following micro-waving and 30% after frying19.
Impact of analytical methodology on published values for food
polyphenol content
Along with the inherent variation in the polyphenol content of
foods, the difficulty in accurately quantifying polyphenols has
further contributed to the limitations of food composition data-
bases. Indeed, standardised analytical methods for quantifying
the polyphenol content of foods are lacking. Two main
approaches have been used to quantify the polyphenol content
of fruits, vegetables and beverages: (1) chromatography tech-
niques, usually HPLC linked with various detection systems
and (2) assays which measure total phenols, most notably
those which quantify the reduction of the Folin-Ciocalteu
reagent20. These different techniques result in another source
of variation in the measurement of polyphenol content.
A measurement of polyphenol content by HPLC usually
yields lower values than those that quantify on the basis of
total polyphenol content. One reason for this is that some
polyphenols may escape determination during HPLC analysis
either because they are uncharacterised or they are not
resolved by the chromatography. On the other hand, an over-
estimation may be generated by the Folin-Ciocalteu assay, as
foods may contain components other than polyphenols, which
act as reducing agents. A good example of such a component
is ascorbic acid, which accounts for about 40% of the esti-
mated total phenols in potato and tomato but only about 5%
of that in onions and apple21. In spite of this problem, most
authors still use data published .25 years ago which utilised
the phenol quantification method22.
The impact of all of these variables on food composition
databases means that often they will provide an inaccurate
representation of the true polyphenol content of the food con-
sumed. Indeed, no accurate food-composition databases have
been produced successfully9, as they have for micronutrients
such as vitamins. The considerable difficulties in assessing
polyphenol intakes using traditional dietary assessment tech-
niques highlight the need for rigorous biomarkers of intake
which may circumvent these limitations.
Factors affecting choice of potential biomarkers of
polyphenols intake
In order to serve as a useful biomarker of intake in nutrition
studies, the criteria listed below need to be satisfied:
1. Quantification of the biomarker of interest should be
qualitatively and quantitatively robust. Therefore, sensi-
tive and specific techniques should be available to accu-
rately quantify the biomarker of interest in tissue/
biofluid, which has been appropriately collected and
stored to ensure minimum biomarker degradation.
2. Concentrations of the biomarker in the tissue/biofluid of
interest should be sensitive to changes in intake of the
dietary component of interest.
3. The biomarker should be specific to the dietary com-
ponent of interest, i.e. variation in its concentration
should be due to changes in the intake of the dietary com-
ponent of interest only.
4. The interpretation of dietary intake–biomarker relation-
ships will require a clear understanding of the impact of
physiological factors and whole diet composition on kin-
etics of absorption, metabolism and excretion of the puta-
tive biomarker.
The remainder of this review will focus on these points in
relation to biomarkers of polyphenol intake.
Metabolic fate of polyphenols
Although the identity of many of the major polyphenols in
plant foods is known, the identification of circulating and
tissue metabolites, which could serve as potential biomarkers
of intake has been undertaken for a small number of polyphe-
nols only. In general, native polyphenols are subjected to
extensive metabolism following ingestion. In the upper gastro-
intestinal tract, dietary polyphenols act as substrates for an
array of enzymes leading to large differences in the proportion
of polyphenols that are absorbed. During transfer across the
jejunum and ileum, polyphenols are subject to extensive
metabolism by phase I hydrolysing and oxidizing enzymes,
J. P. E. Spencer et al.14
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including cytochrome P450 and glucosidase enzymes, and by
phase II conjugating and detoxifying enzymes23–25. The
majority of aglycones, which escape metabolism in the
small intestine, are subject to phase I and II metabolism in
the liver following transfer via the portal blood24,26. Such
enzymes include uridine diphosphate (UDP)-glucuronosyl
transferases, which lead to the formation of O-glucuronides,
sulpho-transferases, which generate O-sulphates and cate-
chol-O-methyl transferases, which produce O-methylated
metabolites. In addition, a large proportion of ingested dietary
polyphenols escape absorption in the stomach and small intes-
tine, including those re-excreted into the gut lumen via the
bile, and pass to the large intestine where they are subjected
to actions of the gut microflora24,27. The colon contains
approximately 1012 microorganisms/cm3 which have enor-
mous catalytic and hydrolytic potential and produce a wide
range of metabolites which are subsequently absorbed into
the systemic circulation from the large bowel. Knowledge of
the extensive metabolism of flavonoids and polyphenols has
challenged the concept that flavonoids are responsible for
the large increases in plasma total antioxidant capacity
observed after the consumption of flavonoid-rich foods.
Many studies, reviewed nicely by Lotito and Frei28, have indi-
cated that increases in plasma antioxidant capacity do not
result due to plasma flavonoids, but are more likely the conse-
quence of increased uric acid levels.
One of the most important factors thought to determine the
subsequent metabolic fate of polyphenols in human subjects is
the quantity ingested. There is a significant difference in the
metabolite profile following the administration of polyphenols
in pharmacological doses compared with that observed follow-
ing consumption of normal dietary quantities. For example,
after the intake of a large dose of pure catechin, free catechin
is detected in the plasma29. In contrast, consumption of a
single serving of red wine, containing 35mg catechin, results
in all the circulating catechin being detected in the conjugated
form30. The appearance of free flavanol in the plasma is likely
to be due to the saturation of phase I and II conjugating
enzymes during the absorption of large amounts of free flava-
nol. In addition, the type of conjugate formed also appears to
vary according to the dose ingested. Sulphation is generally a
higher affinity, lower-capacity pathway relative to glucuroni-
dation, so that as the ingested dose increases, a shift from sul-
phation toward glucuronidation occurs31.
An essential requirement for the characterisation of a poly-
phenol metabolite as a potential biomarker of intake is the
specificity of this metabolite. Such a metabolite should only
appear in human plasma following the intake of a specific poly-
phenol and should not be formed as a product of the metabolism
of any other compound either consumed or produced endogen-
ously. Unfortunately, the ingestion of a number of polyphenols
often leads to the formation of common metabolites in the cir-
culation. For example, metabolism of polyphenols by the intes-
tinal bacteria in the large intestine leads to the formation of
common small-cleavage products25. This has been observed
with caffeic acid intake from coffee, where the colonic-derived
metabolites, hippuric acid and 3-hydroxyhippuric acid, may
also derive from the metabolism of: (1) quinic acid, (2) the aro-
matic amino acids tryptophan, tyrosine and phenylalanine and
(3) other polyphenols which possess a hydroxyl group in
the 3-position of the aromatic ring32. Consequently, such
metabolites are not useful biomarkers for the intake of caffeic
acid. However, isoferulic acid may represent such a biomarker
for caffeic acid intake as it has not been described as a major
constituent of food and is only derived from 4-methoxylation
of caffeic acid prior to or after its absorption32. Further research
is required in order to expand our current knowledge regarding
the biotransformation of the different classes of polyphenols
and to assess the usefulness of such metabolites as biomarkers
of intake.
Analytical techniques used to identify and quantify biomarkers
If specific metabolites are to be used as biomarkers for the
intake of polyphenols, it is essential that analytical techniques
for their measurement in biological samples are both sensitive
and reliable. The circulating concentrations of both native and
metabolic forms of polyphenols are in the nanomolar to low
micromolar range and normally represent only a very small
percentage of the amount consumed. Furthermore, the meta-
bolic forms that predominate are difficult to characterise
and/or quantify due to a lack of suitable standards. Conse-
quently, the most common approach is to quantify the agly-
cones using HPLC coupled with UV spectra, fluorescence or
electrochemical detection following the hydrolysis of polyphe-
nol conjugates with the enzymes b-glucuronidase and/or sul-
phatase. However, accurate quantification may still be
hampered due to the similar retention times of polyphenol
conjugates, leading to misidentification and an inability to
accurately quantify the metabolite of interest33,34. The rela-
tively recent application of HPLC–tandem mass spectrometry
technology has provided a useful tool for the positive identifi-
cation of compounds in biological fluids. This technique is
likely to aid the identification and quantification of polyphe-
nols and their metabolites in biological fluids such as
plasma and urine. Finally, consideration should also be
given to the stability of polyphenol metabolites during
sample storage and during sample extraction. For example,
anthocyanins are highly sensitive to changes in pH and may
undergo ring opening or oxidation during sample extraction
to yield forms that escape detection35.
Response to the dose of polyphenol ingested
A prerequisite for a biomarker is that differences in consump-
tion must be able to be discriminated i.e. the biomarker is
quantitatively associated with intake. Bioavailability and/or
pharmacokinetic studies have shown that plasma metabolite
concentrations achieved following consumption of polyphe-
nols vary greatly according to the nature of the polyphenol,
and in particular the nature of the food source. For example,
consumption of 80–100mg quercetin glycosides results in
plasma concentrations of quercetin metabolites between 0·3
and 0·75mmol/l, whether the flavonol was consumed in the
form of apples, onions, or meals rich in flavonols36–38. Similar
plasma concentrations of catechin and epicatechin are
observed following consumption of green tea (0·1–0·7mmol/
l for an intake of 90–150mg)39, cocoa (0·25–0·7mmol/l for
an intake of 70–165mg)40 or red wine (0·09mmol/l for
an intake of 35mg)41. However, the plasma concentrations
achieved following the administration of similar doses
of different flavanols has been shown to vary greatly, with
Biomarkers for polyphenol intake 15
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levels of catechin peaking at 0·1mM and epicatechin peaking
at 2·6mM following the intake of 160mg catechin and epica-
techin, respectively42. If plasma concentrations are to be
used as a biomarker of intake, more quantitative information
regarding the relationship between dose administered and
plasma concentrations is required.
A more complex picture emerges when one considers the
form (i.e. the type of food) in which the polyphenol is ingested.
The food source is likely to have a large impact on the dose–
response relationship between intake and appearance of a
specific metabolite. This is in part due to the fact that the
food matrix may greatly influence absorption of polyphenols
from the gastrointestinal tract and partly because polyphenols
exist in a variety of chemical forms depending on the food
source. The best-described example of the latter is the impact
of glycosylation on flavonoid absorption. Many studies have
indicated that it is polyphenol aglycones that are transferred
across the enterocyte, with glucosides needing to be enzymati-
cally hydrolysed, by b-glucosidases located in the gut mucosa
or by bacterial enzymes, prior to absorption. Therefore, with
the exception of glucosides, the efficiency of absorption of a
particular polyphenol will be markedly reduced if the dietary
form exists as glycosides. For example, the absorption of quer-
cetin is greater following the ingestion of onions, which are rich
in glucosides, compared with the ingestion of apples, which
contain both glycosides and glucosides36. However, in some
cases, polyphenol glucosides have been shown to be more effi-
ciently absorbed than the free aglycone43,44. This may relate to
their transport into enterocytes by the Na-dependent glucose
transporter, SGLT1, where they are hydrolysed by cytosolic
b-glucosidase. Although the same metabolic pathways apply
to phenolic acids, there are additional complications in that
they are often esterified in plants and their absorption is influ-
enced by the extent to which they are bound to complex poly-
saccharides in plant cell walls. The best-studied example is
ferulic acid, which is often etherified to arabinoxylans in the
outer husks of cereals. Whilst free ferulic acid is absorbed effi-
ciently from tomatoes, leading to relatively high plasma con-
centrations, much lower plasma levels of ferulic acid are
obtained following the ingestion of cereals45.
Although not well studied, evidence suggests that variations
in polyphenol absorption also occur due to interactions
between polyphenols and other food components. For
example, there are contradictory reports regarding the influ-
ence of milk on the absorption of flavonoids. Most studies
indicate that milk does not affect the absorption of catechin,
quercetin or kaempferol when added to green or black
tea46,47, or the absorption of flavanols from chocolate48. How-
ever, another study indicated that plasma epicatechin levels
were reduced by almost 2-fold when dark chocolate was
accompanied by milk or when the chocolate itself contained
milk49. Furthermore, bread- and sugar-containing meals have
been shown to enhance the absorption of catechin and epica-
techin from chocolate, with the authors suggesting that
the carbohydrate composition of the meal may impact on fla-
vonoid absorption through an effect on gastric secretions,
motility and hepatic blood flow50. Consequently, the dose–
response relationship between polyphenol intake and the
concentration of potential biomarker in plasma or urine may
be influenced by both the chemical form of the polyphenol
present in foods and the general food composition.
Lastly, there appears to be considerable inter-individual
variation in the metabolic response to a given dose of a par-
ticular polyphenol-rich food. This is observed particularly in
the case of metabolites produced by colonic microflora. For
example, the formation of equol from daidzein in the gut is
thought to be a clinically relevant step in the therapeutic
potential of soya isoflavones, as the estrogenic potency of
equol is 10-fold higher than its precursor daidzein. However,
it is well recognised that adults differ in their ability to pro-
duce equol, with only 30–40% of individuals producing
equol following daidzein ingestion51. This has been attributed
to an absence of a specific enzyme-producing bacterial species
in the large bowel. However, even for polyphenols for which
absorption is not dependent on bacterial metabolism, there is
considerable inter-individual variation in the dose–response
relationship52. Such variability in absorption or post-absorp-
tive metabolism may be attributed in part to variability in
the expression of metabolising enzymes and transporters due
to genetic variability within the population. Therefore, the
dietary polyphenol–biomarker relationship may be dependent
on inter-individual genetic variability as well as on the food
source.
Kinetics of metabolite/biomarker following exposure
Another vital factor to consider when developing a potential
biomarker of polyphenol intake is the kinetic profile of its
metabolism and appearance in the biofluid. Although the
metabolic pathways to which most polyphenols are subjected
are similar, pharmacokinetic profiles differ markedly among
the different classes of polyphenols. Anthocyanins are
reported to possess the highest rate of absorption, with time
to maximum concentration (Tmax) as low as 0.5 h following
intake of blackcurrant juice, whilst flavanones have a Tmax
in the range 4–6 h53,54. The extended Tmax of flavanones
and other flavonoids relative to anthocyanins probably results
due to the requirement for de-glycosylation in the intestine
prior to absorption. The effect de-glycosylation is highlighted
by studies showing that the absorption kinetics of quercetin
differ greatly depending on the type of glycoside conju-
gation36,37. Quercetin from onions, which contain only gluco-
sides, is rapidly absorbed (Tmax 0.7 h), whereas quercetin
found in apples had a Tmax 2.5 h and pure quercetin-3-rutino-
side, the major species in tea, showed a markedly delayed
absorption (Tmax 9.3 h). These differing absorption profiles
mean that in human investigations there will be different opti-
mal time points for plasma or urine sampling. As metabolite
concentrations are generally low in both urine and plasma, it
is essential that biofluids are collected when these putative
biomarkers are at their highest concentrations. Optimal
sampling of both urine and in particular plasma will improve
reliability of the biomarkers in human studies.
The time–response relationship between intake and appear-
ance of the metabolite biomarker in plasma will also be depen-
dent on the elimination rate of the metabolite. There is limited
data regarding the precise half-lives of polyphenols in plasma.
Data suggest that these half-lives are about 2 h for anthocya-
nins and flavanones53–55 and 2–3 h for flavanols30,56,57. The
rapid excretion of polyphenols is facilitated by the conjugation
of aglycones or O-methylated forms to sulphate or glucuronic
acid. This renders them more polar and thus they undergo
J. P. E. Spencer et al.16
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more rapid renal excretion. However, some studies have
suggested that flavonols, such as quercetin, are eliminated
more slowly with half-lives of 11–28 h37,58. It has been
suggested that this extended half-life may be due to the par-
ticularly high affinity of quercetin for plasma albumin59,60.
This explains the observation that repeated consumption of
onions leads to the accumulation of quercetin in blood61.
The extent to which protein binding contributes to the half-
lives of polyphenols in plasma requires further study. How-
ever, before such a question can be effectively answered,
one must solve the problem of how to extract polyphenols,
including those which are protein bound. Such analytical pro-
blems as well as pharmacokinetic data need to be carefully
considered when interpreting data from human intervention
studies where fasted blood has been sampled. For example,
the quantification of polyphenols in a 10–12 h fasting blood
sample is unlikely to provide useful information regarding
levels of polyphenol intake62.
Many studies to date have analysed plasma polyphenol
levels 1–6 h post intake. Such sampling will provide good
data regarding the polyphenol metabolites of small-intestinal
origin. However, in the majority of cases, such a time
course will not provide information regarding metabolic pro-
ducts formed in the large intestine. For example, the half-
life of isoflavones is 4–10 h if calculated from measurements
of sulphate and glucuronide conjugates only63,64. However,
this increases to more than 2 d if one considers metabolites
of colonic origin, for example the metabolite equol65. The
delayed appearance of colonic metabolites57 may increase
the usefulness of large gut metabolites as potential biomarkers
of acute intake. However, due to the large variation in gut
microflora between individuals, more research is required
before considering the use of bacterial metabolites as potential
biomarkers. Therefore, a sampling regime of between 1 and
3 h is recommended to maximise the chance of quantifying
a blood-borne biomarker of polyphenol intake.
Choice of bio fluid: plasma v. urine
Multiple blood sampling over a 24 h period, and calculations
of concentration via area under the curve, has often been
used in intervention studies to determine the bioavailability
of polyphenols. Urinary excretion of polyphenol metabolites
is often also included in such human studies and is generally
consistent with plasma kinetic data. However, 24 h urine
sampling offers additional advantages over plasma measure-
ments, mainly because it allows for total polyphenol absorp-
tion to be more accurately assessed. Urine sampling is
particularly useful for polyphenols with short half-lives,
where plasma measurements may fail to monitor even
acute intake. The biggest advantage of analysing 24 h urinary
output is that it is quantitative and will provide a measure of
the total output of polyphenol metabolites over a 24 h period.
This is likely to be a more robust may of monitoring daily
intake than a single measurement in plasma, or indeed in
urine. Twenty-four hour urinary data will also provide a
better index of intake, as one may monitor the total concen-
trations of both small- and large-intestinal metabolites, with-
out the need for multiple blood collections. For example,
following the ingestion of a polyphenol-rich meal, the urin-
ary profile indicated that the maximal amount of naringenin
glucuronide occurred in the first 12 h while the maximal con-
centrations of the colonic metabolite 3-hydroxyphenylacetic
acid was reached 60–84 h post ingestion66. Therefore, urin-
ary measurements of polyphenol metabolites provide more
comprehensive data regarding intake, as has been shown
for other phytochemicals such as glucosinolates. Several
studies have indicated that urinary levels of the metabolites
of the glucoraphanin, the predominant glucosinolate in broc-
coli were proportional to the amount of broccoli eaten67,68.
Although urine sampling appears promising, urinary data
may be misleading for certain polyphenols that use alternative
routes of excretion. For example, although the systemic bio-
availability and the maximum plasma concentration of genis-
tein is higher than for daidzein64, a greater urinary excretion of
daidzein is observed69. This appears to be because a greater
fraction of genistein is eliminated in bile70,71. This explanation
is substantiated by plasma kinetic curves in human subjects,
which show an early peak of genistein and related metabolites
in plasma which is closely followed by a second peak 3 h later
reflecting enterohepatic circulation44,72. Considering the above
information, it is clear that the usefulness of urinary polyphe-
nol metabolite output as a biomarker of recent (12–72 h)
intake remains to be fully established.
Assessment of biomarkers for exposure to specific dietary
polyphenols in human blood and urine
The remainder of this review will focus on the potential bio-
markers of polyphenol intake which are currently established.
We comment on their strengths and limitations based on the
criteria established in the previous section.
Flavonoids
Only a limited number of studies have attempted to assess
the usefulness of plasma or urine levels of flavonoids as bio-
markers of intake. Two such studies have investigated the
use of fasting plasma and urine concentrations of quercetin
as biomarkers of intake (Table 1). Consumption of three
different doses of quercetin, ingested as fruit juice, resulted
in a significant dose-dependent increase in urinary quercetin,
indicating that urinary quercetin may serve as a quantitative
biomarker of intake73. In contrast, no dose–response
relationship was evident for plasma levels of quercetin con-
centration in this study. Noroozi and co-workers investigated
plasma quercetin concentrations in diabetic subjects consum-
ing high-flavonol diets containing either 57 or 90mg querce-
tin for 2 weeks74. At the end of the study period, the mean
fasting plasma concentrations were 48 (SD 12) mg/l and 87
(SD 27) mg/l, respectively. In addition, there was a close
correlation between the fasting plasma and 24 h urinary
concentration.
A positive correlation between plasma concentrations and
the intake of citrus flavanones has also been reported by
Manach and co-workers54. Here a dose-dependent relation-
ship between the maximum plasma concentration and 24 h
urinary excretion of hesperetin and naringenin was observed.
However, with a Tmax of approximately 5 h, plasma levels
are only reflective of short-term (,12 h) intake. As with
quercetin, the results suggest that 24 h urinary flavanone
outputs may serve as a more useful biomarker of intake.
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However, the intake–urinary excretion relationship might be
dependent on food source, an observation that requires
further investigation53,54,75. Although positive correlations
between dose and concentration in plasma have been
observed in kinetic studies for flavonols and anthocyanins,
no data are currently available regarding the usefulness of
urinary excretion as a biomarker of intake40,56,76. In contrast,
although the plasma concentrations and urinary output of
isoflavones follow a curvilinear relationship64 (Table 1)
plasma and urinary isoflavone levels are considered as
reliable semi-quantitative indices of intake. Concentrations
of isoflavones and their metabolites were higher in fasting
plasma and in 24 h urine from subjects who consumed a
high-soya diet compared with a low-soya diet for 10
weeks77 (Table 1). In addition, urinary excretion differed
between subjects having 35mg isoflavone supplement/d for
3 months and those following a non-supplemented diet78
(Table 1), and the correlation coefficient (r) describing the
relationship between 24 h excretion and isoflavone intake
was 0·89. This positive correlation between intake and fast-
ing plasma or urine excretion was used to validate a newly
constructed phyto-oestrogen database, containing more than
600 values assigned to foods by using duplicate diet anal-
ysis79. The correlations between estimated intake of phyto-
oestrogens by fourteen subjects, measured by 7-d weighed
intake, and urinary excretion (24 h) and plasma concen-
trations were highly significant (r 0·97 and 0·92, respect-
ively). Therefore, in nutrition research both fasting plasma
concentration and 24 h urinary output can be used as quan-
titative biomarkers of isoflavone intake.
Phenolic acids
The estimation of intake of phenolic acids presents problems
similar to those for flavonoids. However, the identification
of suitable biomarkers of phenolic acids has been hampered
by findings that phenolic acid metabolites may also be
formed from other dietary sources such as flavonoids (dis-
cussed earlier). The main dietary sources of the phenolics
gallic acid and chlorogenic acid are tea and coffee respect-
ively. A number of studies have highlighted the potential use-
fulness of the quantification of the metabolites of these
compounds in plasma/urine as biomarkers of tea and coffee
intake. A bioavailability study of caffeic acid in human volun-
teers consuming 100, 200 and 300ml red wine, indicated that
the plasma concentration achieved 1 h post-ingestion was
dose-dependent80 (Table 1). In another study conducted by
Hodgson and co-workers, 24 h urinary excretion of 4-O-
methylgalllic acid correlated significantly with usual (r 0·50,
P,0·001) and current (r 0·57, P,0·001) tea intake. Isoferulic
acid, a specific metabolite of chlorogenic acid, was also sig-
nificantly but weakly related to usual (r 0·26, P¼0·008) and
current (r 0·18, P,0·001) coffee intake81 (Table 1). In a
recent study fifteen individual polyphenol metabolites were
quantified in 24 h urine samples collected from volunteers fol-
lowing consumption of six different polyphenol-rich bev-
erages82. This study highlighted the potential usefulness of
the quantification of urinary epicatechin, chlorogenic acid
and gallic acid as specific biomarkers of tea, coffee and
wine intakes.
Use of flavonoids in intervention and epidemiological
studies as biomarkers of the intake of, fruit and vegetables,
and other plant-derived foods
Since flavonoids are widely distributed in fruits and veg-
etables, a number of studies have investigated their usefulness
as potential biomarkers of fruit and vegetable intake. In a
strictly controlled dietary intervention study, 24 h urinary out-
puts of flavonoids were measured following 6 weeks con-
sumption of diets either low or high in fruits, vegetables and
berries83 (Table 1). Urinary quercetin and flavanones, as
well as total flavonoid, outputs were clearly higher after the
high-vegetable diet compared with the low-vegetable diet.
At the individual level, a significant positive correlation
between changes in fruit and vegetable intake and changes
in urinary flavonoid excretion was observed. Furthermore,
there was a positive correlation (r 0·86) between total polyphe-
nol metabolites in 24 h urine samples and increasing intake of
fruit and vegetables following a 1-d consumption of a basic
diet supplemented with 300 or 600 g fruit and vegetables84
(Table 1). The total excretion of flavonoids in the morning
urine also increased but the association was weaker (r 0·59).
These studies provide evidence that 24 h urinary excretion of
flavonoids may be used effectively as a biomarker for fruit
and vegetable intake.
However, in epidemiological studies where the potential
health effects of fruit and vegetables are investigated, 24 h
urine samples are rarely collected. Instead only ‘spot’
urine samples or fasting plasma samples are collected. The
usefulness of fasting plasma concentrations of selected fla-
vonoids as markers of ordinary dietary intake has been
investigated by Radtke and co-workers85. Mean intake esti-
mates (7-d period) of quercetin, kaempferol, naringenin
and hesperetin were estimated using literature data on the
flavonoid content of foods. In addition, fasting plasma
samples were taken at the end of the record period for fla-
vonoid determination. For all four flavonoids, there were
significant correlations between 7-d intake results and fast-
ing plasma concentrations. For flavonoids with short half-
lives, distinctly higher correlation coefficients were found
for the relationship between intake estimates for the final
day before blood sampling, and the fasting plasma concen-
trations. Furthermore, a recent report has evaluated the
associations between the intake of polyphenol-rich foods
(estimated from a 2-d dietary record) and the urinary
excretion of several phenolic compounds from spot urine
samples86. Here, apple consumption was positively corre-
lated with phloretin, grapefruit consumption with naringenin,
orange with hesperetin, citrus fruit consumption with both
naringenin and hesperetin (r 0·31–0·57, P,0·05). The com-
bination of fruits and/or fruit juices was positively correlated
with gallic acid and 4-O-methylgallic acid, isorhamnetin,
kaempferol, hesperetin, naringenin and phloretin (r 0·24–
0·44, P,0·05). In addition, coffee consumption was posi-
tively correlated with caffeic and chlorogenic acids (r 0·29
and 0·63, P,0·05 respectively) and black tea and wine con-
sumption were positively correlated with gallic and 4-O-
methylgallic acids (r 0·37–0·54, P,0·001). This study
suggests that several polyphenols measured in a spot urine
sample can be used as biomarkers of polyphenol-rich food
intake86.
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Conclusion
It is clear that the choice of biomarker for the estimation of
polyphenol intake is complex with different classes of flavo-
noids and possibly even individual polyphenols requiring
different approaches. For the majority of flavonoids, which
possess short plasma half-lives, measurement of plasma con-
centrations will provide little information regarding even
acute intakes and quantification of their output in urine may
be a better approach. In addition to scientific considerations,
practical issues may determine the choice of method. The
quantification of a number of metabolites in 24 h urine samples
may be a suitable approach in small-scale human intervention
trials but may not be a realistic possibility in large-scale epide-
miological studies. This is due to problems in organising the
collection of 24 h urine samples from a large study population.
An intermediate approach may be the quantification of metab-
olites in spot urine samples but there is little evidence on
which to assess the suitability of this approach and thus it
should be highlighted as an important area for future research.
This review has focussed on the identification and vali-
dation of individual polyphenols, or their metabolites, that
may represent useful biomarkers of the intake of polyphenols
in human subjects. The majority of potential biomarkers are
those deriving from phase I and II metabolism of flavonoids
and other polyphenols in the small intestine and liver. Metab-
olites such as glucuronide and sulphate conjugates (and related
O-methylated forms) are commonly used to determine the
extent of polyphenol absorption in human subjects and rep-
resent excellent biomarkers providing researchers employ
careful analytical techniques. In addition to these well charac-
terised metabolic forms, there is great potential for cellular
metabolites of polyphenols, such as glutathionyl and cysteinyl
conjugates87,88, to act as specific biomarkers of polyphenol
intake, as they are likely to be present in significant amounts
in both blood and urine. There are also a number of other can-
didates, such as valerolactones for flavanol intake57, isoferulic
acid for chlorogenic acid ingestion32 and homovanillic alcohol
for the intake of hydroxytyrosol89. In summary, quantification
of specific flavonoid and polyphenol biomarkers in accessible
fluid/tissues holds great potential as an alternative approach to
traditional dietary assessment techniques and will undoubtedly
provide invaluable information regarding the intake of poly-
phenols in human subjects.
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